Levodopa-Induced Dyskinesia in Parkinson's Disease

This book aims to provide a single reference source on levodopa-induced dyskinesias (LID) from ‘bench to bedside’. Initial chapters review the clinical features and phenomenology of LID with video examples; epidemiology and genetic risk factors for LID are covered as a background to understanding ri...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
מחבר תאגידי: SpringerLink (Online service)
מחברים אחרים: Fox, Susan H. (Editor, http://id.loc.gov/vocabulary/relators/edt), Brotchie, Jonathan M. (Editor, http://id.loc.gov/vocabulary/relators/edt)
פורמט: אלקטרוני ספר אלקטרוני
שפה:English
יצא לאור: London : Springer London : Imprint: Springer, 2014.
מהדורה:1st ed. 2014.
נושאים:
גישה מקוונת:https://doi.org/10.1007/978-1-4471-6503-3
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
תוכן הענינים:
  • Phenomenology of Levodopa-Induced Dyskinesia
  • Dyskinesia Rating Scales in Parkinson's Disease
  • Epidemiology of Levodopa-Induced Dyskinesia
  • Risk Factors for Levodopa-Induced Dyskinesia
  • Pharmacological Treatment Options for Levodopa-Induced Dyskinesia
  • Surgical Options for Levodopa-Induced Dyskinesia in Parkinson’s Disease
  • Basal Ganglia Circuitry Models of L-DOPA-Induced Dyskinesia
  • Basal Ganglia Circuitry Models of L-DOPA-Induced Dyskinesia
  • Pharmacological Properties of Levodopa
  • Dopamine Receptors and LID
  • The Serotonergic System In Levodopa-Induced Dyskinesia
  • The Opioid System in Levodopa-Induced Dyskinesia
  • Glutamate Receptors and Levodopa-Induced Dyskinesia
  • Cannabinoids and Levodopa-Induced Dyskinesia
  • The Role of the Noradrenergic System and its Receptors In Levodopa-Induced Dyskinesia
  • Involvement of the Cholinergic System in Levodopa-Induced Dyskinesia
  • New Clinical Trials for Levodopa-Induced Dyskinesia
  • Preclinical Models of Levodopa-Induced Dyskinesia
  • Final Thoughts: Summary and Future Therapeutic Strategies in LID.